02480.HK

Aug 9, 2026, 11:41 UTC

Green Bamboo Biotech announced that the Phase III clinical trial results of its core product LZ901 vaccine in China were published in Nature Communications on August 7, 2026, showing high protective efficacy and good safety in preventing herpes zoster in adults aged 40 and above.